# Comparison of Dexmedetomidine and Meperidine for the Prevention of Shivering Following Coronary Artery Bypass Graft

Study · id `cardio:ct-nct04735965` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04735965](<https://clinicaltrials.gov/study/NCT04735965>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04735965

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 180 participants.

## Technical summary

Registry record NCT04735965. Randomized; quadruple masking; primary purpose prevention. Start 2021-07-15 (actual); primary completion 2022-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 180 participants (planned count; ClinicalTrials.gov record NCT04735965, source copy `cardio:ctgov-nct04735965-2022-01-10`, retrieved 2026-10-26)
- Started: 2021-07-15 (actual) (ClinicalTrials.gov record NCT04735965, source copy `cardio:ctgov-nct04735965-2022-01-10`, retrieved 2026-10-26)
- Primary completion: 2022-07 (anticipated) (ClinicalTrials.gov record NCT04735965, source copy `cardio:ctgov-nct04735965-2022-01-10`, retrieved 2026-10-26)
- Completion: 2022-08 (anticipated) (ClinicalTrials.gov record NCT04735965, source copy `cardio:ctgov-nct04735965-2022-01-10`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04735965, source copy `cardio:ctgov-nct04735965-2022-01-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04735965-2022-01-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of Dexmedetomidine and Meperidine for the Prevention of Shivering Following Coronary Artery Bypass Graft
- Condition: Coronary Artery Disease
- Condition: Postoperative Shivering
- Intervention (Drug): Dexmedetomidine
- Intervention (Drug): Meperidine
- Intervention (Drug): Placeb
- Lead sponsor: Qianfoshan Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Qianfoshan Hospital (`cardio:org-qianfoshan-hospital`)

## Provenance

Content hash: 5973e08be334b4263e491b03788b8ab55f44f0964c56397eed31b465021de341
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
